Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Holding TERN?
Track your performance easily

Terns Pharmaceuticals (TERN) Ownership - Who Owns Terns Pharmaceuticals?

235 Followers

Terns Pharmaceuticals (TERN) Ownership Overview

18.22%12.72%53.13%15.94%
18.22% Insiders
53.13% Other Institutional Investors
― ETFs
15.94% Public Companies and
Individual Investors
The ownership structure of Terns Pharmaceuticals (TERN) stock is a mix of institutional, retail, and individual investors. , 18.22% is owned by Insiders, and 15.94% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 17, 2024
Hongbo Lu
Director
xxxxxxxxxxxxx
$4999995
Aug 05, 2024
xxxxxxxxxxxxx
$47117
Jul 17, 2024
Carl Gordon
Director, >10% Owner
xxxxxxxxxxxxx
$561640
Jul 17, 2024
Orbimed Advisors Llc
Director, >10% Owner
xxxxxxxxxxxxx
$561640

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,180,917Institution4.95%41,892,788
2,678,225Institution3.17%26,835,815
2,247,744Institution2.66%22,522,395
1,825,586Institution2.16%18,292,372
1,083,905Institution1.28%10,860,728
1,075,000Institution1.27%10,771,500
799,126Institution0.95%8,007,243
748,996Institution0.89%7,504,940
745,044Institution0.88%7,465,341
464,389Institution0.55%4,653,178

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,180,917Institution4.95%41,892,788
1,825,586Institution2.16%18,292,372
799,126Institution0.95%8,007,243
464,389Institution0.55%4,653,178
454,600Institution0.54%4,555,092
378,922Institution0.45%3,796,798
366,835Institution0.43%3,675,687
365,662Institution0.43%3,663,933
234,702Institution0.28%2,351,714
229,756Institution0.27%2,302,155

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,543,598Institution1.83%15,466,852
1,293,066Institution1.53%10,021,262
510,117Institution0.60%5,111,372
536,463Institution0.64%4,157,588
308,238Institution0.37%3,088,545
226,039Institution0.27%1,751,802
165,792Institution0.20%1,664,552
134,425Institution0.16%1,346,939
123,751Institution0.15%1,242,460
119,099Institution0.14%923,017

FAQ

Who Owns Terns Pharmaceuticals (TERN)?
According to the latest TipRanks data, approximately 53.13% of the company's stock is held by institutional investors, 18.22% is held by insiders, and 15.94% is held by retail investors.
    What percentage of Terns Pharmaceuticals (TERN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 53.13% of Terns Pharmaceuticals (TERN) stock is held by institutional investors.
      What percentage of Terns Pharmaceuticals (TERN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 15.94% of Terns Pharmaceuticals (TERN) stock is held by retail investors.
        Who owns the most shares of Terns Pharmaceuticals (TERN)?
        Fidelity Securities Fund owns the most shares of Terns Pharmaceuticals (TERN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis